#72 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
If you use hemp CBD because your state doesn’t have a medical cannabis program or because prescriptions are too expensive, you could lose access in November with no alternative in place.
Americans for Safe Access warns that patients who turned to hemp-derived CBD due to cost, access deserts, and limited state medical programs may face sudden loss of access when the Nov ban hits. The FDA’s cannabinoid deadline doesn’t establish clinical pathways, insurance coverage, or patient safeguards. Despite the Dec 2025 Executive Order acknowledging flaws, the Administration can’t revise the Controlled Substances Act. State program improvements are patients’ best hope.
“There is no patient transition plan,none,and that means millions of Americans who depend on affordable hemp CBD for pain, anxiety, and sleep are about to be abandoned by their own government.”
THE PATIENTS THE HEMP BAN FORGOT
The policy debate around the November hemp ban centers on industry economics, regulatory frameworks, and legal definitions. But there’s a human dimension that gets far less attention: the patients.
Americans for Safe Access issued a pointed warning as the Feb 10 FDA deadline approached. Millions of Americans turned to hemp-derived CBD not because they preferred unregulated products, but because they had no alternative. State medical cannabis programs are limited in scope, expensive to access, and simply unavailable in many parts of the country. Hemp CBD was affordable, widely accessible, andโunder the 2018 Farm Billโlegal.
The November ban removes that option without creating a replacement. The new law establishes no clinical pathways. There are no insurance coverage provisions. No patient safeguards. No transition plan for the people who depend on these products.
The December 2025 Executive Order acknowledged the law’s flaws. But executive orders can’t revise the Controlled Substances Act. Only Congress can change the statutory THC limits.
State program improvementsโexpanded qualifying conditions, lower costs, broader accessโare the most realistic path to maintaining patient access. But building those programs takes time, and November is nine months away.
Have thoughts on this? Share it:
๐ฌ Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan โ
Want to discuss this topic with other patients and caregivers? Join the forum discussion โ